10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2015 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2015 10-K (Filed: Feb 19, 2016) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2015 | Dec 31, 2014 | |
| Assets Abstract | ||
| Current Assets | ||
| Cash and cash equivalents | $ 3,666,400 | 3,871,600 |
| Short-term investments | 785,400 | 955,400 |
| Accounts receivable, net of allowances of $44.3 (2015) and $55.0 (2014) | 3,513,000 | 3,234,600 |
| Other receivables | 558,600 | 566,700 |
| Inventories | 3,445,800 | 2,740,000 |
| Prepaid expenses and other | 604,400 | 560,000 |
| Total current assets | 12,573,600 | 11,928,300 |
| Other Assets | ||
| Restricted cash | 0 | 5,405,600 |
| Investments | 3,646,600 | 4,568,900 |
| Goodwill | 4,039,900 | 1,758,100 |
| Other intangibles, net | 5,034,800 | 2,884,200 |
| Sundry | 2,220,500 | 1,798,600 |
| Total other assets | 14,941,800 | 16,415,400 |
| Property and equipment, net | 8,053,500 | 7,963,900 |
| Total assets | 35,568,900 | 36,307,600 |
| Liabilities and Shareholders' Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt | 6,100 | 2,688,700 |
| Accounts payable | 1,338,200 | 1,128,100 |
| Employee compensation | 967,000 | 759,000 |
| Sales rebates and discounts | 2,560,100 | 2,068,800 |
| Dividends payable | 539,000 | 530,300 |
| Income taxes payable | 358,900 | 93,500 |
| Other current liabilities | 2,460,300 | 2,472,600 |
| Total current liabilities | 8,229,600 | 9,741,000 |
| Other Liabilities | ||
| Long-term debt | 7,972,400 | 5,332,800 |
| Accrued retirement benefits | 2,160,300 | 2,562,900 |
| Long-term income taxes payable | 868,900 | 998,500 |
| Other noncurrent liabilities | 1,747,400 | 2,284,300 |
| Total other liabilities | 12,749,000 | 11,178,500 |
| Eli Lilly and Company Shareholders' Equity | ||
| Common stock | 691,300 | 694,600 |
| Additional paid-in capital | 5,552,100 | 5,292,300 |
| Retained earnings | 16,011,800 | 16,482,700 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss | (4,580,700) | (3,991,800) |
| Cost of common stock in treasury | (90,000) | (91,400) |
| Total Eli Lilly and Company shareholders' equity | 14,571,300 | 15,373,200 |
| Noncontrolling interests | 19,000 | 14,900 |
| Total equity | 14,590,300 | 15,388,100 |
| Total liabilities and equity | 35,568,900 | 36,307,600 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2015 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |